172 related articles for article (PubMed ID: 16296946)
1. Advances and challenges in fluoropyrimidine pharmacogenomics and pharmacogenetics.
Soong R; Diasio RB
Pharmacogenomics; 2005 Dec; 6(8):835-47. PubMed ID: 16296946
[TBL] [Abstract][Full Text] [Related]
2. Implications of dihydropyrimidine dehydrogenase on 5-fluorouracil pharmacogenetics and pharmacogenomics.
Mattison LK; Soong R; Diasio RB
Pharmacogenomics; 2002 Jul; 3(4):485-92. PubMed ID: 12164772
[TBL] [Abstract][Full Text] [Related]
3. The role of pharmacogenetics and pharmacogenomics in cancer chemotherapy with 5-fluorouracil.
Diasio RB; Johnson MR
Pharmacology; 2000 Sep; 61(3):199-203. PubMed ID: 10971206
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants influencing fluoropyrimidine based-therapy and available methods to detect them.
Di Francia R; Cimino L; Berretta M
Eur Rev Med Pharmacol Sci; 2012 Mar; 16(3):285-98. PubMed ID: 22530343
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics and pharmacogenomics as tools in cancer therapy.
Rodríguez-Vicente AE; Lumbreras E; Hernández JM; Martín M; Calles A; Otín CL; Algarra SM; Páez D; Taron M
Drug Metab Pers Ther; 2016 Mar; 31(1):25-34. PubMed ID: 26863347
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics of fluoropyrimidine and cisplatin. A future application to gastric cancer treatment.
Shimoyama S
J Gastroenterol Hepatol; 2009 Jun; 24(6):970-81. PubMed ID: 19638079
[TBL] [Abstract][Full Text] [Related]
7. [Polygenetic pharmacogenomic strategies to identify drug sensitivity biomarkers].
Nishiyama M
Gan To Kagaku Ryoho; 2005 Nov; 32(12):1902-7. PubMed ID: 16282724
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics and pharmacogenomics: development, science, and translation.
Weinshilboum RM; Wang L
Annu Rev Genomics Hum Genet; 2006; 7():223-45. PubMed ID: 16948615
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
Yan L; Beckman R
Biotechniques; 2005 Oct; 39(10 Suppl):S565-8. PubMed ID: 18957038
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomics: historical perspective and current status.
Charlab R; Zhang L
Methods Mol Biol; 2013; 1015():3-22. PubMed ID: 23824846
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics in dermatology: a patient-centered update.
Comfere NI; Ikediobi ON; Peters MS; el-Azhary RA; Gibson LE
Int J Dermatol; 2013 Aug; 52(8):1005-12. PubMed ID: 23786543
[TBL] [Abstract][Full Text] [Related]
12. Chemistry of Fluorinated Pyrimidines in the Era of Personalized Medicine.
Gmeiner WH
Molecules; 2020 Jul; 25(15):. PubMed ID: 32751071
[TBL] [Abstract][Full Text] [Related]
13. Identification of a candidate single-nucleotide polymorphism related to chemotherapeutic response through a combination of knowledge-based algorithm and hypothesis-free genomic data.
Takahashi H; Kaniwa N; Saito Y; Sai K; Hamaguchi T; Shirao K; Shimada Y; Matsumura Y; Ohtsu A; Yoshino T; Takahashi A; Odaka Y; Okuyama M; Sawada J; Sakamoto H; Yoshida T
J Biosci Bioeng; 2013 Dec; 116(6):768-73. PubMed ID: 23816762
[TBL] [Abstract][Full Text] [Related]
14. Cancer pharmacogenomics: achievements in basic research.
Nakajima M; Yokoi T
Int J Clin Oncol; 2005 Feb; 10(1):14-9. PubMed ID: 15729595
[TBL] [Abstract][Full Text] [Related]
15. Cancer pharmacogenomics: international trends.
Yamayoshi Y; Iida E; Tanigawara Y
Int J Clin Oncol; 2005 Feb; 10(1):5-13. PubMed ID: 15729594
[TBL] [Abstract][Full Text] [Related]
16. 5-Fluorouracil derivatives: a patent review.
Álvarez P; Marchal JA; Boulaiz H; Carrillo E; Vélez C; Rodríguez-Serrano F; Melguizo C; Prados J; Madeddu R; Aranega A
Expert Opin Ther Pat; 2012 Feb; 22(2):107-23. PubMed ID: 22329541
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomics of brain cancer and personalized medicine in malignant gliomas.
Shai RM; Reichardt JK; Chen TC
Future Oncol; 2008 Aug; 4(4):525-34. PubMed ID: 18684063
[TBL] [Abstract][Full Text] [Related]
18. The role of pharmacogenetics in chemotherapy: modulation of tumour response and host toxicity.
Boddy AV; Idle JR
Cancer Surv; 1993; 17():79-104. PubMed ID: 8137354
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
Yan L; Beckman RA
Biotechniques; 2005 Oct; 39(4):565-8. PubMed ID: 16235569
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics: bench to bedside.
Weinshilboum R; Wang L
Nat Rev Drug Discov; 2004 Sep; 3(9):739-48. PubMed ID: 15340384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
